News

New treatment for severe spinal cord injury in small dogs achieves exceptional success rate

7 November 2025

A minimally-invasive treatment for severe intervertebral disc disease in small dog breeds is now available at the University of Cambridge’s Queen’s Veterinary School Hospital – the only place in the UK currently providing the procedure. Our aim is to give owners more choice, particularly where surgery may be difficult, and...

Cambridge researchers awarded prestigious Synergy Grants from European Research Council

7 November 2025

Seven researchers at the University of Cambridge have been awarded Synergy Grants from the European Research Council to lead five new collaborative projects that will tackle some of science’s toughest puzzles. Teams of researchers will join forces to address the most complex scientific problems together - this time, they...

Cambridge researcher awarded Schmidt Sciences fellowship to ensure AI benefits society

7 November 2025

Cambridge researcher Dr Miles Cranmer is one of 28 researchers worldwide to receive an AI2050 fellowship from Schmidt Sciences, awarded to researchers studying how to fulfil AI’s potential to benefit humankind. The fellows will pursue efforts to solve challenging problems in AI by building AI scientists, designing safer...

Neighbourhood deprivation linked to brain vessel damage and higher dementia risk

7 November 2025

Cambridge researchers have discovered why living in a disadvantaged neighbourhood may be linked to an increase in an individual’s risk of dementia. In research published today, they show how it is associated with damage to brain vessels – which can affect cognition – and with poorer management of lifestyle factors known to...

UK organisations release statistics for use of animals in research in 2024

24 October 2025

The 10 organisations in Great Britain that carry out the highest number of animal procedures - those used in medical, veterinary and scientific research - have released their annual statistics today. "Animal research... is an essential step in the development of new medicines, vaccines and treatments for both humans and...

Dementia linked to problems with brain’s waste clearance system

24 October 2025

Problems with the brain’s waste clearance system could underlie many cases of dementia and help explain why poor sleep patterns and cardiovascular risk factors such as high blood pressure increase the risk of dementia. A study led by researchers at the University of Cambridge found that impaired movement of cerebrospinal...

Addenbrooke’s begins innovative liver cancer treatment for first patients in Europe

24 October 2025

A Cambridge patient has become the first person in Europe to receive cutting-edge histotripsy treatment outside of a clinical trial, after the technology was fast-tracked by the Government - marking a major milestone in NHS cancer care. The pioneering procedure, which uses ultrasound energy to destroy tumours, took place...

Four Cambridge innovations awarded UKRI proof of concept funding

23 October 2025

Four cutting-edge University of Cambridge research projects are to receive funding from UKRI to grow into market-leading products and services. A total of 48 projects from across the UK are receiving funding from a new £9 million proof of concept programme to support and accelerate the development of new or improved...

Study reveals genetic and developmental differences in people with earlier versus later autism diagnosis

9 October 2025

Researchers find different genetic profiles related to two trajectories that autistic children tend to follow. One linked to early diagnosis, and communication difficulties in infancy. The other linked to later diagnosis, increased social and behavioural difficulties in adolescence, and higher rates of conditions like ADHD...

Parkinson’s ‘trigger’ directly observed in human brain tissue for the first time

9 October 2025

Scientists have, for the first time, directly visualised and quantified the protein clusters believed to trigger Parkinson’s, marking a major advance in the study of the world’s fastest-growing neurological disease. These tiny clusters, called alpha-synuclein oligomers, have long been considered the likely culprits for...

New treatment for severe spinal cord injury in small dogs achieves exceptional success rate

Cambridge researchers awarded prestigious Synergy Grants from European Research Council

Cambridge researcher awarded Schmidt Sciences fellowship to ensure AI benefits society

Neighbourhood deprivation linked to brain vessel damage and higher dementia risk

UK organisations release statistics for use of animals in research in 2024

Dementia linked to problems with brain’s waste clearance system

Addenbrooke’s begins innovative liver cancer treatment for first patients in Europe

Four Cambridge innovations awarded UKRI proof of concept funding

Study reveals genetic and developmental differences in people with earlier versus later autism diagnosis

Parkinson’s ‘trigger’ directly observed in human brain tissue for the first time

Study at Cambridge

About the University

Research at Cambridge